Loading…
Kyowa Hakko Bio plans to invest 10 billion yen (about $91.1 million) by 2020 to double capacity at its Chinese and Thai plants. The plants make amino acids for medical care.
The company cites growing demand in emerging countries.
The expansion targets medical-grade amino acids rather than feed grades, so the direct effect on feed amino acid supply and prices is minimal.
asia.nikkei.comAug 18, 2017Not enough comparable past events yet for a historical read.
Moves of each commodity's benchmark from the last close before the event. Historical reads pool past events of the same kind; they describe what happened, not what will. Not investment advice.
